MAR 06, 2020 9:07 PM PST

Drug Improves Cancer Therapy

WRITTEN BY: Nouran Amin

Prochlorperazine (PCZ) is a drug used for psychiatric use and the therapeutic treatment of nausea but was recently found to block the internalization of molecular receptors on the surface of tumor cells allowing more effective anticancer antibodies to avoid immune evasion.

"This represents a potentially disruptive change in clinical approaches to improve therapeutic targeting as the opportunity of temporarily moving drug targets within patient tumor cells becomes possible," says senior author Fiona Simpson, a cancer researcher at the University of Queensland.

PCZ was used as the temporary treatment of cancer in some patients and results yielded receptor clustering inside cancer cells of patients. Findings were published in the journal Cell.

"These findings highlight the crucial role of availability and persistence of the molecule targeted by the therapeutic antibody at the cell surface of tumor cells," Simpson says.

PCZ is also used in laboratory studies to inhibit a cellular process known as endocytosis—a mechanism that brings outside substances to the inside of the cell. Such inhibition has held clinical relevance for the control of viral infection.

Learn more about endocytosis:

To apply the mechanisms of PCZ, researchers analyzed tumor samples from patients and found a decrease in endocytosis of a protein known as epidermal growth factor receptor (EGFR). The particular protein was found to be inhibited by a cancer therapeutic called cetuximab.

"We found that if we stopped the drug targets getting inside the cells by inhibiting the uptake process, called endocytosis, we got a really big immune response against the tumors in mice," Simpson says. "This led to the concept that temporarily halting endocytosis of receptors that are the targets of monoclonal antibody therapies may be used to improve clinical outcomes.”

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 06, 2021
Infographics
Psychedelic Medicine 101
APR 06, 2021
Psychedelic Medicine 101
As clinical trials for psychedelics progress, interest in psychedelics is increasing among pharmaceutical firms, clinici ...
MAR 18, 2021
Technology
Technology Fixes Errors Associated with Self-Administering Medications
MAR 18, 2021
Technology Fixes Errors Associated with Self-Administering Medications
Almost all medications allow patients to self-administer—however, that does not mean that they always get it right ...
MAY 02, 2021
Cannabis Sciences
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
MAY 02, 2021
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
Current research suggests that cannabidiol (CBD) oil may be effective in managing seizures in childhood-onset epilepsy. ...
MAY 12, 2021
Cardiology
Reversing the Heart Damage Seen in Marfan Syndrome
MAY 12, 2021
Reversing the Heart Damage Seen in Marfan Syndrome
Marfan syndrome is a genetic disorder that disrupts the connective tissues that anchor and link the body's organs, affec ...
MAY 17, 2021
Immunology
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
MAY 17, 2021
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
Inflammation, a process that was meant to defend our body from infection, has been found to contribute to a wide range o ...
JUN 01, 2021
Cannabis Sciences
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
JUN 01, 2021
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
As laws around cannabinoids continue to evolve, some people with chronic illnesses such as multiple sclerosis (MS), are ...
Loading Comments...